Rathbones Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Rathbones Group’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20,400	Closed	-$105K	–	343
2019 Q2	$105K	Hold	20,400	–	–	﹤0.01%	301
2019 Q1	$73K	Hold	20,400	–	–	﹤0.01%	299
2018 Q4	$125K	Hold	20,400	–	–	﹤0.01%	297
2018 Q3	$119K	Hold	20,400	–	–	﹤0.01%	286
2018 Q2	$87K	Hold	20,400	–	–	﹤0.01%	289
2018 Q1	$90K	Hold	20,400	–	–	﹤0.01%	298
2017 Q4	$107K	Hold	20,400	–	–	﹤0.01%	304
2017 Q3	$125K	Buy	20,400 +1,500	+8%	+$9.49K	0.01%	296
2017 Q2	$137K	Hold	18,900	–	–	0.01%	293
2017 Q1	$100K	Hold	18,900	–	–	﹤0.01%	305
2016 Q4	$136K	Buy	18,900 +1,000	+6%	+$8.09K	0.01%	294
2016 Q3	$168K	Hold	17,900	–	–	0.01%	286
2016 Q2	$113K	Hold	17,900	–	–	0.01%	287
2016 Q1	$99K	Hold	17,900	–	–	0.01%	288
2015 Q4	$57K	Buy	17,900 +7,000	+64%	+$46.3K	﹤0.01%	288
2015 Q3	$92K	Buy	+10,900	New	+$184K	0.01%	293

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Rathbones Group's PETX Position: Q3 2019 in Review

Rathbones Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 20,400 shares — an estimated $105K sold.

Rathbones Group first reported a position in PETX in Q3 2015 and held it in 16 quarters. The position peaked at $168K in Q3 2016. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Rathbones Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Rathbones Group sold 20,400 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $105K.
Rathbones Group first reported a position in Aratana Therapeutics, Inc. in Q3 2015 and held it in 16 quarters.
Rathbones Group's Aratana Therapeutics, Inc. position peaked at $168K in Q3 2016.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Rathbones Group's 13F filing for Q3 2019, filed 13 Nov 2019.